ACUTA CAPITAL PARTNERS, LLC ELVN Holdings History
ACUTA CAPITAL PARTNERS, LLC's Enliven Therapeutics Inc Holding Summary
As of 2025-03-31, ACUTA CAPITAL PARTNERS, LLC held 115,805.00 shares of Enliven Therapeutics Inc(ELVN), totaling N/A. This investment constitutes 0% of their stock portfolio, and ACUTA CAPITAL PARTNERS, LLC now holds 0.24% of the outstanding Enliven Therapeutics Inc(ELVN) stock.
The initial trade took place in 2023Q1. And since then ACUTA CAPITAL PARTNERS, LLC has made 5 purchases of ELVN, at an average price of $17.97, for a total of 548,062.00 shares. In addition, there have been 4 sales at an average price of $22.54 for 282,793.00 shares. Based on historical transaction data and ELVN's current price of $19.93, ACUTA CAPITAL PARTNERS, LLC's estimated gain on his ELVN holdings is $1.81 Mil, reflecting a 18.40% gain to date.
ACUTA CAPITAL PARTNERS, LLC ELVN ($19.93) Holding Chart
ACUTA CAPITAL PARTNERS, LLC ELVN ($19.93) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
